JP2011500814A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500814A5
JP2011500814A5 JP2010531058A JP2010531058A JP2011500814A5 JP 2011500814 A5 JP2011500814 A5 JP 2011500814A5 JP 2010531058 A JP2010531058 A JP 2010531058A JP 2010531058 A JP2010531058 A JP 2010531058A JP 2011500814 A5 JP2011500814 A5 JP 2011500814A5
Authority
JP
Japan
Prior art keywords
mammal
molecular entity
cyclic peptide
antibody
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010531058A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500814A (ja
JP5581490B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012151 external-priority patent/WO2009055054A2/en
Publication of JP2011500814A publication Critical patent/JP2011500814A/ja
Publication of JP2011500814A5 publication Critical patent/JP2011500814A5/ja
Application granted granted Critical
Publication of JP5581490B2 publication Critical patent/JP5581490B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010531058A 2007-10-25 2008-10-24 抗体媒介による細菌のクオラムセンシングの破壊 Expired - Fee Related JP5581490B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98259307P 2007-10-25 2007-10-25
US60/982,593 2007-10-25
PCT/US2008/012151 WO2009055054A2 (en) 2007-10-25 2008-10-24 Antibody-mediated disruption of quorum sensing in bacteria

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014124700A Division JP6183910B2 (ja) 2007-10-25 2014-06-17 抗体媒介による細菌のクオラムセンシングの破壊

Publications (3)

Publication Number Publication Date
JP2011500814A JP2011500814A (ja) 2011-01-06
JP2011500814A5 true JP2011500814A5 (https=) 2011-06-02
JP5581490B2 JP5581490B2 (ja) 2014-09-03

Family

ID=40580303

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010531058A Expired - Fee Related JP5581490B2 (ja) 2007-10-25 2008-10-24 抗体媒介による細菌のクオラムセンシングの破壊
JP2014124700A Expired - Fee Related JP6183910B2 (ja) 2007-10-25 2014-06-17 抗体媒介による細菌のクオラムセンシングの破壊
JP2017140405A Pending JP2018021021A (ja) 2007-10-25 2017-07-19 抗体媒介による細菌のクオラムセンシングの破壊

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014124700A Expired - Fee Related JP6183910B2 (ja) 2007-10-25 2014-06-17 抗体媒介による細菌のクオラムセンシングの破壊
JP2017140405A Pending JP2018021021A (ja) 2007-10-25 2017-07-19 抗体媒介による細菌のクオラムセンシングの破壊

Country Status (9)

Country Link
US (2) US9394371B2 (https=)
EP (2) EP2211889B1 (https=)
JP (3) JP5581490B2 (https=)
KR (1) KR101557173B1 (https=)
CN (2) CN101835484B (https=)
AU (1) AU2008317331B2 (https=)
CA (2) CA2975568A1 (https=)
ES (1) ES2603061T3 (https=)
WO (1) WO2009055054A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014066677A1 (en) 2012-10-26 2014-05-01 Sorrento Therapeutics Inc. Anti-infective binding proteins that bind aip2
DE102013211850A1 (de) * 2013-06-21 2014-12-24 Gilupi Gmbh Schnelltest zum Nachweisen von Erregermaterial, insbesondere zur Unterstützung der Diagnose einer Sepsis, sowie Kit und Vorrichtung zur Durchführung eines Sepsistests
ES2860952T3 (es) * 2013-08-01 2021-10-05 Univ Catholique Louvain Proteína anti-garp y usos de la misma
KR20160102210A (ko) 2013-12-27 2016-08-29 노버스 인터내쇼날 인코포레이티드 에톡시화 계면활성제
CN106459956B (zh) * 2014-01-29 2019-12-17 一般财团法人化学及血清疗法研究所 抗-运甲状腺素蛋白人抗体
KR102538555B1 (ko) 2014-01-29 2023-05-30 케이엠 바이올로직스 가부시키가이샤 항-트랜스티레틴 인간화 항체
EP3103808B1 (en) * 2014-02-07 2018-08-22 Miyarisan Pharmaceutical Co., Ltd. Peptide having activity of inhibiting production of toxin by bacterium belonging to genus clostridium
US10821167B2 (en) * 2016-02-02 2020-11-03 Unm Rainforest Innovations VLP-based vaccines for targeting Staphylococcus aureus secreted virulence factors
WO2018031730A2 (en) * 2016-08-11 2018-02-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide inhibitors of phosphoglycerate mutase and methods of use
WO2018152452A1 (en) 2017-02-17 2018-08-23 Mapp Biopharmaceutical, Inc. Monoclonal antibodies and cocktails for treatment of ebola infections
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
MX2020002013A (es) * 2017-08-31 2020-07-13 Univ California Bacterioterapia molecular para control de la actividad enzimatica de la piel.
ES2960419T3 (es) 2017-09-15 2024-03-04 Lentigen Tech Inc Composiciones y métodos de tratamiento de cáncer con inmunoterapia anti-CD19
US10774135B2 (en) 2017-12-22 2020-09-15 Sorrento Therapeutics, Inc. Variant antibodies that bind AIP2
US11459445B2 (en) 2018-02-13 2022-10-04 Sumitomo Chemical Company, Limited Composition and molded body
CA3150161A1 (en) 2019-08-13 2021-02-18 Darlene E. MCCORD Non-activated, amorphous, ph neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
CN111573853B (zh) * 2020-05-29 2020-11-20 南京大学 一种削减生物法处理废水毒性的方法
EP4423197A4 (en) 2021-10-25 2025-08-27 Darlene E Mccord COATED MEDICINAL CLAY COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND DELIVERY OF CATION SOURCES AND METHODS OF USE THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2256465A1 (en) * 1996-05-22 1997-11-27 New York University Blocking expression of virulence factors in s. aureus
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
JP2003532698A (ja) * 2000-05-10 2003-11-05 プリンストン ユニバーシティ 細菌の増殖および病理発生を調節するための化合物ならびに方法
US7786257B2 (en) * 2000-12-18 2010-08-31 University Of Kansas Signal-1/signal-2 bifunctional peptide inhibitors
US6463632B2 (en) * 2001-02-07 2002-10-15 Hans Oetiker Ag Maschinen-Und Apparatefabrik Guide arrangement for tightening tool emplacement in hose clamps provided with plastically deformable ears
CN1164612C (zh) * 2001-09-11 2004-09-01 四川新泰克控股有限责任公司 人工组合的抗菌工程多肽及其制备方法
EP1528935B1 (en) * 2002-08-13 2012-03-21 Haptogen Ltd Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody

Similar Documents

Publication Publication Date Title
JP2011500814A5 (https=)
IL325353A (en) Incretin analogs and their use
JP2011500725A5 (https=)
JP2013507439A5 (https=)
RU2007139915A (ru) Haemophilus influenzae типа в
JP2015520184A5 (https=)
JP2015518825A5 (https=)
JP2022546878A5 (https=)
JP2011518179A5 (https=)
RU2007101039A (ru) Иммуностимулирующие олигонуклеотидные мультимеры
JP2011511778A5 (https=)
JP2012532185A5 (https=)
JP2008540565A5 (https=)
JP2007529528A5 (https=)
JP2010505831A5 (https=)
JP2008538183A5 (https=)
JP2019031567A5 (https=)
JP2005537234A5 (https=)
RU2012121264A (ru) Терапевтические пептиды
FI3793587T3 (fi) PTH-konjugaattien aloitusannos
JP2018532715A5 (https=)
NZ602693A (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
JP2010505865A5 (https=)
JP2006506942A5 (https=)
CN111971038A (zh) 用于双靶向治疗神经内分泌瘤的组合物和方法